Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study

Roche rheumatoid arthritis drug fails to help COVID-19 patients in Italian study

In the study, Actemra did not reduce severe respiratory symptoms, intensive care visits, or death any better than standard treatments. The trial, which enrolled 126 patients – about one third of the intended number – was stopped early after an interim analysi…

Read More…

You May Also Like